Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Comparator in Chinese Subjects with cSSSI
NCT00772447Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2008
- Primary completion
- Sep 2010
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daptomycin in Complicated skin and skin structure infection (cSSSI), sponsored by AstraZeneca. Started Sep 2008; status: completed.
02
Drugs
daptomycin
03
Conditions
Complicated skin and skin structure infection (cSSSI)
Beyond the preview
Go deeper on NCT00772447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772447.